ArticleBioanalysis2024
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats.
Hongxin Cai, Xiaoyue Du, Yufeng Deng, Dejian Cao, Lele Wang, Zhiguo Wu, Xianchao Zhang, Jinbiao Xu, Baogang Xie
Open access · greenAbstract read
In one paragraphArticle in Bioanalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 3 institutions in 1 country.
Hongxin CaiSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310000, China.
Xiaoyue DuSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310000, China.
Yufeng DengSchool of Pharmaceutical Science, Nanchang University, Nanchang, 330001, China.
Dejian CaoMedical College of Jiaxing University, Key Laboratory of Medical Electronics & Digital Health of Zhejiang Province, Jiaxing University, Jiaxing, 314001, China.
Lele WangMedical College of Jiaxing University, Key Laboratory of Medical Electronics & Digital Health of Zhejiang Province, Jiaxing University, Jiaxing, 314001, China.
Zhiguo WuSchool of Pharmaceutical Science, Nanchang University, Nanchang, 330001, China.
Xianchao ZhangMedical College of Jiaxing University, Key Laboratory of Medical Electronics & Digital Health of Zhejiang Province, Jiaxing University, Jiaxing, 314001, China.
Jinbiao XuMedical College of Jiaxing University, Key Laboratory of Medical Electronics & Digital Health of Zhejiang Province, Jiaxing University, Jiaxing, 314001, China.
Baogang XieSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310000, China.ORCID 0000-0002-0685-1346 Jiaxing University · CNZhejiang Chinese Medical University · CNNanchang University · CN
Funding
National Natural Science Foundation of China 82374096Zhejiang Chinese Medical University Postgraduate Scientific Research Fund Project 2022YKJ24
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, HepatocellularLiver NeoplasmsNiacinamidePhenylurea CompoundsSorafenibAnimalsAntineoplastic AgentsChromatography, High Pressure LiquidMaleMass SpectrometryRatsRats, Sprague-DawleyAntineoplastic AgentsNiacinamidePhenylurea CompoundsSorafenibhepatocellular carcinomametabolismMichaelis constantpharmacokineticssorafenib
Identifiers
PMID38530220
PMCPMC11216244
OpenAlexW4393181967
What OpenQuestion holds
Textmetadata
Read underepoch 390